Computational pathology company Proscia lands $23M in Series B funding

Digital pathology startup Proscia landed $23 million in Series B funding. The latest round was led by Scale Venture Partners with participation from Hitachi Ventures.

This comes roughly two years after the company closed its $8.5 million Series A round of funding.

Proscia plans to use the new money to build out its commercial efforts and global sales and marketing. It is also looking at expanding its technology, in particular its AI application portfolio.